Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways
CN Serhan - Annu. Rev. Immunol., 2007 - annualreviews.org
Resolution of inflammation and the return of tissues to homeostasis are essential. Efforts to
identify molecular events governing termination of self-limited inflammation uncovered …
identify molecular events governing termination of self-limited inflammation uncovered …
Gastric mucosal defense and cytoprotection: bench to bedside
L Laine, K Takeuchi, A Tarnawski - Gastroenterology, 2008 - Elsevier
The gastric mucosa maintains structural integrity and function despite continuous exposure
to noxious factors, including 0.1 mol/L HCl and pepsin, that are capable of digesting tissue …
to noxious factors, including 0.1 mol/L HCl and pepsin, that are capable of digesting tissue …
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation
M Romano, E Cianci, F Simiele, A Recchiuti - European journal of …, 2015 - Elsevier
The resolution of the inflammatory response is highly regulated by the timely biosynthesis of
a number of endogenous lipid mediators. Among these, lipoxins (LX) and their 15-epimers …
a number of endogenous lipid mediators. Among these, lipoxins (LX) and their 15-epimers …
Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution
CN Serhan - Prostaglandins, leukotrienes and essential fatty acids, 2005 - Elsevier
Lipoxins (LXs) or the lipoxygenase interaction products are generated from arachidonic acid
via sequential actions of lipoxygenases and subsequent reactions to give specific …
via sequential actions of lipoxygenases and subsequent reactions to give specific …
Prevalence and mechanism of nonsteroidal anti-inflammatory drug–induced clinical relapse in patients with inflammatory bowel disease
K Takeuchi, S Smale, P Premchand, L Maiden… - Clinical …, 2006 - Elsevier
Background & Aims: It has been variably suggested that nonselective NSAIDs and
cyclooxygenase (COX)-2 selective inhibitors aggravate or ameliorate clinical disease activity …
cyclooxygenase (COX)-2 selective inhibitors aggravate or ameliorate clinical disease activity …
cellular and molecular mechanisms of NSAID‐induced peptic ulcers
C Musumba, DM Pritchard… - Alimentary …, 2009 - Wiley Online Library
Background Nonsteroidal anti‐inflammatory drugs (NSAIDs) are some of the most
prescribed drugs worldwide and have now probably overtaken Helicobacter pylori as the …
prescribed drugs worldwide and have now probably overtaken Helicobacter pylori as the …
Markedly reduced toxicity of a hydrogen sulphide‐releasing derivative of naproxen (ATB‐346)
JL Wallace, G Caliendo, V Santagada… - British journal of …, 2010 - Wiley Online Library
Background and purpose: Hydrogen sulphide is an important mediator of gastric mucosal
defence. The use of non‐steroidal anti‐inflammatory drugs continues to be limited by their …
defence. The use of non‐steroidal anti‐inflammatory drugs continues to be limited by their …
Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide–releasing diclofenac derivative in the rat
JL Wallace, G Caliendo, V Santagada, G Cirino… - Gastroenterology, 2007 - Elsevier
Background & Aims: Gastrointestinal damage caused by nonsteroidal anti-inflammatory
drugs (NSAIDs) remains a significant clinical problem. Hydrogen makes an important …
drugs (NSAIDs) remains a significant clinical problem. Hydrogen makes an important …
[HTML][HTML] Safety of surfactant excipients in oral drug formulations
S Maher, C Geoghegan, DJ Brayden - Advanced Drug Delivery Reviews, 2023 - Elsevier
Surfactants are a diverse group of compounds that share the capacity to adsorb at the
boundary between distinct phases of matter. They are used as pharmaceutical excipients …
boundary between distinct phases of matter. They are used as pharmaceutical excipients …
15-epi-lipoxin A4–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation
MJ Paul-Clark, T Van Cao, N Moradi-Bidhendi… - The Journal of …, 2004 - rupress.org
The established model for the mechanism of action of aspirin is the inhibition of
prostaglandin synthesis. However, this has never fully explained aspirin's repertoire of …
prostaglandin synthesis. However, this has never fully explained aspirin's repertoire of …